Skip to main content

Table 6 Baseline serum brain-derived neurotrophic factor (BDNF) levels of responders and non-responders at week 6

From: Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial

 

Responders, n = 24

Non-responders, n = 29

Statistics

P

Levels at baseline

 Mature BDNF (ng/mL), mean (SD)

12.8 (3.8)

13.4 (3.4)

t = −0.67, df = 51

0.51

 ProBDNF (pg/mL), median [quartiles]

607.5 [84.4, 5158.3]

135.0 [45.6, 2803.5]

Z = −1.3

0.18

 Ratio of mature BDNF/proBDNFa

25.7 [2.3, 146.8]

105.7 [4.7, 309.2]

Z = −1.3

0.21

  1. Responders and non-responders were assessed at week 6
  2. BDNF brain-derived neurotrophic factor, SD standard deviation
  3. aRatio is serum level of mature BDNF (pg/mL) divided by that of proBDNF (pg/mL) in each individual. Serum mature BDNF levels were analyzed using Student t test. Serum proBDNF and ratio of mature BDNF/proBDNF were analyzed using Mann–Whitney U test